Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PCSK9 Enzyme in Non-Cholesterol Biological Pathways: In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme

NCT06675994 is registered in ClinicalTrials.gov with LifeBridge Health as lead sponsor.

NCT NCT06675994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06675994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PCSK9 Enzyme in Non-Cholesterol Biological Pathways: In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme
Lead sponsor
LifeBridge Health
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
December 30, 2025
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, family history of cerebrovascular disease, family history of coronary artery disease, family history of peripheral artery disease, healthy, hypercholesterolemia, hypertension, overweight, prediabetes